Clinical Trial Update: pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating pTVG-HP in combination with nivolumab for non-metastatic PSA-recurrent prostate cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• nivolumab (nivolumab)
• pTVG-HP

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-12-06